Diagnostic Utility of ANG in Coronary Heart Disease Complicating Chronic Heart Failure: A Cross-Sectional Study

Table 1

Clinical characteristics and plasma ANG levels of patients and controls included in the study.

	CHF	CHD disease control	Healthy control
	203	413	53
Age
Male sex
Hypertension			None
Diabetes mellitus			None
Dyslipidemia			None
Myocardial infarction			None
Angina			None
ALT (U/I)
BUN (μmol/L)
FPG
TC (mmol/L)
TG (mmol/L)
hs-CRP
NT-proBNP (pg/mL)
LVEF (%)
LAD (mm)
LVEDD (mm)
LVESD (mm)
ANG (ng/mL)

compared with healthy controls.
compared with CHD disease controls.
CHD: coronary heart disease; CHF: chronic heart failure; LT: alanine aminotransferase; BUN: blood urea nitrogen; FPG: fasting plasma glucose; TC: total cholesterol; TG: triglyceride. NT-proBNP: N-terminal pro-B-type natriuretic peptide; LVEF: left ventricular ejection fraction; LAD: left atrial diameter; LVEDD: left ventricular end-diastolic dimension; LVESD: left ventricular end-systolic dimension; values are expressed as mean ± SD, as median (IQR), or as indicated.